AmerCare

AmerCare targets non-clinical healthcare service companies — businesses that provide essential operational and administrative support to hospitals, physician groups, and other providers. This includes segments like revenue cycle management, medical waste disposal, healthcare staffing back-office, and provider credentialing services. The firm avoids clinical practices, diagnostic labs, and direct patient-care businesses.

AmerCare operates as a permanent-hold holding company, not a closed-end private equity fund with a fixed exit timeline. It acquires majority stakes in businesses with the intent to hold them indefinitely, reinvesting operating cash flows into new acquisitions. This structural difference means AmerCare does not face pressure to sell portfolio companies within a 5–7 year window, and can prioritize long-term operational performance over short-term EBITDA optimization.

No. AmerCare typically retains the founder-led management teams of acquired companies and provides equity incentives to align interests post-acquisition. The firm views the existing operator expertise as the core asset of the acquisition. Its role is to provide capital, centralized back-office support, and strategic guidance while keeping the operating DNA intact.

Public records suggest AmerCare sources deals through proprietary outreach to founder-owners in fragmented healthcare services niches. These are often business owners approaching retirement who lack an internal succession path and are not on the radar of large institutional buyers. The firm likely uses industry networks, trade associations, and direct introductions rather than broad auction processes.

Based on available public records, AmerCare's portfolio and acquisitions are concentrated in the United States, specifically the Mid-Atlantic and Northeast regions. Its headquarters in Exton, Pennsylvania places it within close reach of dense healthcare markets including Philadelphia, New Jersey, and the broader eastern Pennsylvania corridor.